Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
Healthcare
$18.98 -0.05%
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
52W Low $15.35High $20.30
Volume 0.37M
Average 0.43M
ODTX Common Stock Issued
Cash raised by issuing new shares.
No reported Common Stock Issued figures are available to summarize.
Common Stock Issued history
Currency unavailable · from the cash flow
No Common Stock Issued data reported for this period type.
Common Stock Issued vs competitors
How ODTX compares with its peers on the latest reported figures
ODTX Competitors
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
ORKAOruka Therapeutics, Inc. | LTM Sep 2026 | $830.71M USD | +2715.7% | — | — |
| LTM Sep 2026 | $757.86M USD | +235.4% | +94.3% | 837.5% | |
ALMSAlumis Inc. Common Stock | LTM Jun 2026 | $360.93M USD | +86.0% | — | 4878.8% |
| LTM Mar 2026 | $254.1M USD | +241.8% | +18.3% | — | |
| LTM Mar 2026 | $58.03M USD | -22.6% | — | 693.6% | |
| LTM Jun 2026 | $41.61M USD | +34.5% | +17.1% | 14.8% | |
| LTM Mar 2026 | $27.99M USD | -72.1% | +6.4% | 12.0% | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | — | — | — | — | — |
| Peer median (excluding ODTX) | — | +86.0% | +17.7% | 693.6% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Currency unavailable
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.